Conference Program Home
My Program
All Times EDT
Legend:
CC = Walter E. Washington Convention Center M = Marriott Marquis Washington, DC
* = applied session ! = JSM meeting theme
Activity Details
|
|
|
|
138 * !
|
Mon, 8/8/2022,
10:30 AM -
12:20 PM
|
CC-202B
|
|
Dose Optimization in Drug Development: Where We Are, and Where We Want to Be — Topic Contributed Papers
|
|
Biopharmaceutical Section, Biometrics Section, Health Policy Statistics Section
|
|
Organizer(s): Bo Huang, Pfizer Inc.
|
|
Chair(s): Bo Huang, Pfizer Inc.
|
|
10:35 AM
|
A Bayesian Predictive Platform Design for Proof of Concept and Dose-Finding Using Early and Late Endpoints
Ruitao Lin, MD Anderson; Li Wang, Abbvie; Peter Thall, The University of Texas MD Anderson Cancer Center; Ying Yuan , the University of Texas MD Anderson Cancer Center
|
|
10:55 AM
|
Statistical Methods for Dose Optimization in Oncology; One Size Does Not Fit All
Roberto Bugarini, Pfizer Inc.; Wei Zhong, Pfizer Inc.; Christophe Le Corre, Pfizer Inc.; Cynthia Basu, Pfizer Inc.; Ray Li, Pfizer Inc.
|
|
11:15 AM
|
Dose-Finding in Retinal Gene Therapy Trials – Optical Illusion or Not?
Jialin Xu, Janssen; George Capuano, Janssen
|
|
11:35 AM
|
Data-Informed Oncology Dosing Decisions: Trade-Off Between Efficacy/Safety/Convenience Including a Case Study with a Bi-Specific Immunotherapy
Erik Rasmussen, Amgen
|
|
11:55 AM
|
Bayesian Approaches to Identify Multiple Recommended Phase 2 Doses
Erik Bloomquist, Ph.D.; Jianjin Xu, FDA/CDER
|
|
12:15 PM
|
Floor Discussion
|
Video Available to all JSM Registered Attendees. Please login to view.
|
